Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Head and Neck Neoplasms | 38 | 2024 | 2712 | 2.580 |
Why?
|
Paranasal Sinus Neoplasms | 13 | 2024 | 234 | 2.400 |
Why?
|
Free Tissue Flaps | 15 | 2024 | 320 | 1.940 |
Why?
|
Carcinoma, Squamous Cell | 31 | 2023 | 4029 | 1.880 |
Why?
|
Skull Base | 5 | 2017 | 299 | 1.690 |
Why?
|
Nose Neoplasms | 8 | 2023 | 245 | 1.400 |
Why?
|
Oropharyngeal Neoplasms | 10 | 2023 | 475 | 1.320 |
Why?
|
Surgical Flaps | 19 | 2021 | 1634 | 1.230 |
Why?
|
Deglutition Disorders | 3 | 2023 | 604 | 1.100 |
Why?
|
Laryngectomy | 7 | 2023 | 248 | 1.080 |
Why?
|
Mouth Neoplasms | 6 | 2023 | 601 | 1.060 |
Why?
|
Parotid Neoplasms | 5 | 2020 | 155 | 1.050 |
Why?
|
Tongue Neoplasms | 4 | 2023 | 179 | 1.000 |
Why?
|
Skull Base Neoplasms | 5 | 2017 | 284 | 0.880 |
Why?
|
Carcinoma, Adenoid Cystic | 9 | 2022 | 252 | 0.860 |
Why?
|
Papillomavirus Infections | 8 | 2023 | 1585 | 0.850 |
Why?
|
Esophageal Stenosis | 1 | 2023 | 194 | 0.830 |
Why?
|
Laryngeal Neoplasms | 6 | 2018 | 512 | 0.810 |
Why?
|
Esthesioneuroblastoma, Olfactory | 5 | 2023 | 55 | 0.800 |
Why?
|
Nasal Cavity | 6 | 2023 | 312 | 0.730 |
Why?
|
Speech Disorders | 2 | 2021 | 189 | 0.660 |
Why?
|
Temporal Bone | 3 | 2014 | 661 | 0.640 |
Why?
|
Glossectomy | 2 | 2023 | 58 | 0.580 |
Why?
|
Lymphatic Metastasis | 4 | 2022 | 2906 | 0.550 |
Why?
|
DNA Helicases | 1 | 2020 | 861 | 0.500 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2014 | 40 | 0.480 |
Why?
|
Hypopharyngeal Neoplasms | 3 | 2012 | 50 | 0.460 |
Why?
|
Rectus Abdominis | 1 | 2012 | 94 | 0.430 |
Why?
|
Salivary Ducts | 1 | 2012 | 24 | 0.420 |
Why?
|
Skull Fractures | 1 | 2013 | 195 | 0.420 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 5 | 2021 | 312 | 0.420 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2012 | 61 | 0.410 |
Why?
|
Ear Neoplasms | 3 | 2014 | 117 | 0.400 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2020 | 3471 | 0.380 |
Why?
|
Histones | 1 | 2020 | 2597 | 0.360 |
Why?
|
Human papillomavirus 11 | 1 | 2009 | 14 | 0.360 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2009 | 57 | 0.350 |
Why?
|
Neoplasm Invasiveness | 9 | 2023 | 3612 | 0.350 |
Why?
|
Postoperative Complications | 15 | 2024 | 15244 | 0.330 |
Why?
|
Papilloma | 1 | 2009 | 148 | 0.320 |
Why?
|
Retrospective Studies | 46 | 2024 | 77098 | 0.320 |
Why?
|
Carcinoma | 4 | 2015 | 2374 | 0.310 |
Why?
|
Neoplasm Recurrence, Local | 9 | 2022 | 9185 | 0.300 |
Why?
|
Surgical Wound Infection | 5 | 2021 | 1538 | 0.300 |
Why?
|
Parotid Gland | 4 | 2023 | 168 | 0.300 |
Why?
|
Nasal Mucosa | 2 | 2021 | 373 | 0.290 |
Why?
|
Carrier Proteins | 1 | 2020 | 5019 | 0.290 |
Why?
|
Skull Neoplasms | 1 | 2007 | 173 | 0.290 |
Why?
|
Cell Proliferation | 3 | 2020 | 10472 | 0.270 |
Why?
|
Larynx, Artificial | 3 | 2011 | 69 | 0.270 |
Why?
|
Papillomaviridae | 4 | 2022 | 1118 | 0.270 |
Why?
|
Duodenal Neoplasms | 1 | 2006 | 106 | 0.260 |
Why?
|
Humans | 107 | 2024 | 742088 | 0.250 |
Why?
|
Laryngeal Diseases | 2 | 2020 | 241 | 0.250 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2020 | 1038 | 0.250 |
Why?
|
Keratins | 1 | 2006 | 515 | 0.240 |
Why?
|
Neoplasm Staging | 12 | 2023 | 11001 | 0.230 |
Why?
|
Chemokine CXCL9 | 1 | 2023 | 132 | 0.230 |
Why?
|
Tracheotomy | 2 | 2018 | 166 | 0.220 |
Why?
|
Thigh | 1 | 2004 | 247 | 0.220 |
Why?
|
Cell Differentiation | 1 | 2020 | 11470 | 0.220 |
Why?
|
Combined Modality Therapy | 9 | 2021 | 8621 | 0.220 |
Why?
|
Mucins | 1 | 2006 | 564 | 0.210 |
Why?
|
Dilatation | 1 | 2023 | 286 | 0.210 |
Why?
|
Middle Aged | 48 | 2024 | 213127 | 0.210 |
Why?
|
Osteopontin | 1 | 2023 | 296 | 0.200 |
Why?
|
Antibiotic Prophylaxis | 3 | 2016 | 638 | 0.200 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 329 | 0.200 |
Why?
|
Disease-Free Survival | 8 | 2019 | 6891 | 0.200 |
Why?
|
Prosthesis Implantation | 3 | 2011 | 641 | 0.200 |
Why?
|
Adenoma | 1 | 2012 | 2168 | 0.190 |
Why?
|
Male | 58 | 2024 | 349538 | 0.190 |
Why?
|
Female | 57 | 2024 | 379592 | 0.190 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2002 | 371 | 0.180 |
Why?
|
Trachea | 3 | 2011 | 1075 | 0.180 |
Why?
|
Blood Transfusion | 2 | 2018 | 1296 | 0.180 |
Why?
|
Oral Surgical Procedures | 2 | 2021 | 168 | 0.180 |
Why?
|
Treatment Outcome | 22 | 2023 | 62966 | 0.180 |
Why?
|
Parathyroidectomy | 1 | 2002 | 235 | 0.180 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1095 | 0.180 |
Why?
|
Cell Polarity | 1 | 2023 | 644 | 0.180 |
Why?
|
Neck | 1 | 2004 | 693 | 0.180 |
Why?
|
Immunohistochemistry | 6 | 2019 | 11363 | 0.180 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2019 | 123 | 0.170 |
Why?
|
Aged | 39 | 2021 | 162944 | 0.170 |
Why?
|
Prognosis | 13 | 2023 | 29010 | 0.170 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2940 | 0.170 |
Why?
|
Salvage Therapy | 4 | 2015 | 1269 | 0.170 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 221 | 0.170 |
Why?
|
Chemokines, CXC | 1 | 2020 | 422 | 0.160 |
Why?
|
Head | 1 | 2004 | 878 | 0.160 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2019 | 88 | 0.160 |
Why?
|
Thyroidectomy | 2 | 2015 | 877 | 0.160 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2018 | 61 | 0.160 |
Why?
|
Nose Deformities, Acquired | 1 | 2018 | 44 | 0.160 |
Why?
|
Radiotherapy, Adjuvant | 5 | 2020 | 1769 | 0.160 |
Why?
|
Epiglottis | 1 | 2017 | 79 | 0.150 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2019 | 713 | 0.150 |
Why?
|
Neck Dissection | 4 | 2023 | 196 | 0.150 |
Why?
|
Neoplasm Metastasis | 5 | 2019 | 4839 | 0.150 |
Why?
|
Laryngoplasty | 1 | 2017 | 53 | 0.150 |
Why?
|
Scapula | 1 | 2018 | 162 | 0.150 |
Why?
|
Ear Auricle | 2 | 2014 | 32 | 0.140 |
Why?
|
Oropharynx | 3 | 2014 | 127 | 0.140 |
Why?
|
Esthetics | 2 | 2015 | 306 | 0.140 |
Why?
|
Skin Neoplasms | 4 | 2023 | 5662 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2023 | 971 | 0.140 |
Why?
|
Esophagus | 3 | 2011 | 1017 | 0.140 |
Why?
|
Macrophages | 2 | 2023 | 5655 | 0.140 |
Why?
|
Gene Amplification | 1 | 2020 | 1062 | 0.130 |
Why?
|
Skin Transplantation | 2 | 2018 | 1074 | 0.130 |
Why?
|
Cervicoplasty | 1 | 2015 | 8 | 0.130 |
Why?
|
Arteries | 2 | 2022 | 1118 | 0.130 |
Why?
|
Adenocarcinoma | 4 | 2009 | 6347 | 0.130 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 786 | 0.130 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 577 | 0.130 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3564 | 0.130 |
Why?
|
Speech Intelligibility | 1 | 2015 | 81 | 0.130 |
Why?
|
Diagnosis, Differential | 8 | 2020 | 12958 | 0.130 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 546 | 0.130 |
Why?
|
Intraoperative Complications | 1 | 2002 | 1188 | 0.130 |
Why?
|
Hypersensitivity | 1 | 2024 | 1093 | 0.130 |
Why?
|
Histoplasma | 1 | 2014 | 41 | 0.130 |
Why?
|
Clostridium Infections | 1 | 2021 | 548 | 0.120 |
Why?
|
Bacteremia | 1 | 2021 | 962 | 0.120 |
Why?
|
Endoscopy | 2 | 2015 | 1774 | 0.120 |
Why?
|
Receptor, Notch1 | 1 | 2017 | 502 | 0.120 |
Why?
|
Mouth | 1 | 2017 | 373 | 0.120 |
Why?
|
Histoplasmosis | 1 | 2014 | 66 | 0.120 |
Why?
|
Survival Rate | 9 | 2021 | 12773 | 0.120 |
Why?
|
Skull Fracture, Basilar | 1 | 2013 | 6 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 602 | 0.120 |
Why?
|
Exosomes | 1 | 2018 | 412 | 0.120 |
Why?
|
Palatine Tonsil | 1 | 2014 | 193 | 0.120 |
Why?
|
Postoperative Hemorrhage | 2 | 2015 | 409 | 0.120 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1274 | 0.120 |
Why?
|
Colonic Neoplasms | 1 | 2006 | 2542 | 0.120 |
Why?
|
Frameshift Mutation | 1 | 2015 | 399 | 0.120 |
Why?
|
Length of Stay | 6 | 2021 | 6294 | 0.120 |
Why?
|
Otolaryngology | 1 | 2020 | 644 | 0.120 |
Why?
|
Pharyngeal Diseases | 1 | 2014 | 132 | 0.110 |
Why?
|
Fractures, Comminuted | 1 | 2013 | 52 | 0.110 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2013 | 80 | 0.110 |
Why?
|
Pharyngectomy | 3 | 2011 | 45 | 0.110 |
Why?
|
Genes, p53 | 1 | 2015 | 755 | 0.110 |
Why?
|
Databases, Genetic | 1 | 2020 | 1780 | 0.110 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 655 | 0.110 |
Why?
|
Papillomavirus Vaccines | 1 | 2019 | 489 | 0.110 |
Why?
|
Gastrostomy | 1 | 2015 | 309 | 0.110 |
Why?
|
Parotid Diseases | 1 | 2012 | 46 | 0.110 |
Why?
|
Transferrin | 1 | 2013 | 295 | 0.110 |
Why?
|
Lymphocytes | 1 | 2020 | 2614 | 0.110 |
Why?
|
Chromatin | 2 | 2022 | 2917 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6534 | 0.100 |
Why?
|
Sphenoid Sinus | 2 | 2009 | 100 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2020 | 4438 | 0.100 |
Why?
|
Graft Survival | 4 | 2015 | 3733 | 0.100 |
Why?
|
Olfactory Mucosa | 1 | 2011 | 98 | 0.100 |
Why?
|
Adult | 22 | 2021 | 213712 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3444 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2015 | 837 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1638 | 0.090 |
Why?
|
Fibula | 2 | 2024 | 269 | 0.090 |
Why?
|
Chordoma | 1 | 2013 | 359 | 0.090 |
Why?
|
Tongue | 2 | 2023 | 406 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1144 | 0.090 |
Why?
|
Pneumonia | 1 | 2021 | 2117 | 0.090 |
Why?
|
Reoperation | 3 | 2015 | 4200 | 0.090 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2011 | 150 | 0.080 |
Why?
|
Optic Disk Drusen | 1 | 2009 | 35 | 0.080 |
Why?
|
Risk Assessment | 5 | 2021 | 23320 | 0.080 |
Why?
|
Liposarcoma | 1 | 2012 | 333 | 0.080 |
Why?
|
Quality of Life | 6 | 2024 | 12730 | 0.080 |
Why?
|
Hemangiosarcoma | 1 | 2011 | 236 | 0.080 |
Why?
|
Pneumocephalus | 1 | 2008 | 46 | 0.080 |
Why?
|
Rhinitis | 1 | 2015 | 691 | 0.080 |
Why?
|
Forearm | 2 | 2023 | 407 | 0.080 |
Why?
|
Aged, 80 and over | 12 | 2021 | 57683 | 0.080 |
Why?
|
Cell Line, Tumor | 2 | 2022 | 16665 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5851 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1237 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3639 | 0.070 |
Why?
|
Ear, External | 1 | 2007 | 160 | 0.070 |
Why?
|
Ear Canal | 1 | 2007 | 146 | 0.070 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9410 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 2956 | 0.070 |
Why?
|
Risk Factors | 10 | 2020 | 72145 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3585 | 0.070 |
Why?
|
Developing Countries | 2 | 2016 | 2789 | 0.070 |
Why?
|
Keratin-20 | 1 | 2006 | 31 | 0.070 |
Why?
|
Sinusitis | 1 | 2015 | 922 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7790 | 0.070 |
Why?
|
Keratin-7 | 1 | 2006 | 57 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7721 | 0.070 |
Why?
|
Mucin-2 | 1 | 2006 | 49 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2019 | 2986 | 0.070 |
Why?
|
Cohort Studies | 6 | 2024 | 40450 | 0.070 |
Why?
|
Carcinoma, Basal Cell | 2 | 2008 | 545 | 0.070 |
Why?
|
Hematocrit | 2 | 2018 | 636 | 0.060 |
Why?
|
Ear, Middle | 1 | 2007 | 332 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 6 | 2013 | 20086 | 0.060 |
Why?
|
Cutaneous Fistula | 2 | 2016 | 78 | 0.060 |
Why?
|
Nose | 2 | 2019 | 509 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2948 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2020 | 13029 | 0.060 |
Why?
|
Punctures | 3 | 2011 | 372 | 0.060 |
Why?
|
Cheek | 1 | 2004 | 63 | 0.060 |
Why?
|
Pilot Projects | 3 | 2023 | 8297 | 0.060 |
Why?
|
Lip Neoplasms | 1 | 2004 | 37 | 0.060 |
Why?
|
Follow-Up Studies | 7 | 2015 | 39004 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3667 | 0.060 |
Why?
|
Poverty | 1 | 2016 | 2646 | 0.060 |
Why?
|
Transcription Factors | 2 | 2022 | 12164 | 0.060 |
Why?
|
Skull | 1 | 2008 | 810 | 0.060 |
Why?
|
Bacteria | 1 | 2014 | 2102 | 0.060 |
Why?
|
Survival Analysis | 2 | 2014 | 10248 | 0.060 |
Why?
|
Patient Readmission | 1 | 2017 | 3111 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3691 | 0.060 |
Why?
|
Massachusetts | 4 | 2017 | 8662 | 0.060 |
Why?
|
Postoperative Period | 2 | 2018 | 1839 | 0.050 |
Why?
|
Lip | 1 | 2004 | 195 | 0.050 |
Why?
|
Mastoid | 2 | 2014 | 92 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5462 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 687 | 0.050 |
Why?
|
Salivary Gland Neoplasms | 2 | 2017 | 297 | 0.050 |
Why?
|
Incidence | 6 | 2015 | 20928 | 0.050 |
Why?
|
Xenobiotics | 1 | 2002 | 73 | 0.050 |
Why?
|
Face | 1 | 2008 | 993 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2274 | 0.050 |
Why?
|
Algorithms | 2 | 2015 | 13853 | 0.050 |
Why?
|
Sensation | 1 | 2023 | 337 | 0.050 |
Why?
|
Curriculum | 1 | 2014 | 3589 | 0.050 |
Why?
|
Weight-Bearing | 1 | 2024 | 514 | 0.050 |
Why?
|
Graft Rejection | 1 | 2014 | 4393 | 0.050 |
Why?
|
Young Adult | 7 | 2021 | 56350 | 0.050 |
Why?
|
Hypocalcemia | 1 | 2002 | 191 | 0.050 |
Why?
|
Radiotherapy Dosage | 3 | 2016 | 2876 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2023 | 21719 | 0.050 |
Why?
|
Intubation, Intratracheal | 1 | 2008 | 1357 | 0.050 |
Why?
|
Radius | 1 | 2023 | 422 | 0.040 |
Why?
|
Deglutition | 1 | 2021 | 197 | 0.040 |
Why?
|
Time Factors | 3 | 2021 | 40054 | 0.040 |
Why?
|
Palate, Soft | 1 | 2019 | 96 | 0.040 |
Why?
|
Poly I-C | 1 | 2019 | 115 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1640 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4681 | 0.040 |
Why?
|
Neovascularization, Pathologic | 2 | 2015 | 2633 | 0.040 |
Why?
|
Maxilla | 1 | 2021 | 469 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4440 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12242 | 0.040 |
Why?
|
Catheter-Related Infections | 1 | 2021 | 252 | 0.040 |
Why?
|
Radiotherapy | 2 | 2021 | 1525 | 0.040 |
Why?
|
Calcinosis | 1 | 2007 | 1497 | 0.040 |
Why?
|
Palate | 1 | 2018 | 123 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 548 | 0.040 |
Why?
|
Prolapse | 1 | 2017 | 68 | 0.040 |
Why?
|
Facial Nerve | 1 | 2020 | 271 | 0.040 |
Why?
|
Dissection | 1 | 2019 | 294 | 0.040 |
Why?
|
Cicatrix | 1 | 2023 | 761 | 0.040 |
Why?
|
Mutation | 2 | 2023 | 29717 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 2021 | 632 | 0.040 |
Why?
|
Clonal Anergy | 1 | 2017 | 169 | 0.040 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2018 | 534 | 0.040 |
Why?
|
Perception | 1 | 2023 | 1188 | 0.040 |
Why?
|
Tomography, Optical Coherence | 1 | 2009 | 2637 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12344 | 0.040 |
Why?
|
Oncogenes | 1 | 2022 | 1263 | 0.040 |
Why?
|
Adolescent | 7 | 2017 | 85649 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2017 | 35342 | 0.040 |
Why?
|
Sarcoma | 1 | 2008 | 1895 | 0.030 |
Why?
|
Clindamycin | 1 | 2016 | 139 | 0.030 |
Why?
|
Speech | 1 | 2021 | 540 | 0.030 |
Why?
|
Facial Paralysis | 1 | 2020 | 338 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2016 | 173 | 0.030 |
Why?
|
Lymphatic Irradiation | 1 | 2016 | 104 | 0.030 |
Why?
|
Prospective Studies | 4 | 2021 | 53187 | 0.030 |
Why?
|
Vision Disorders | 2 | 2015 | 1057 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1333 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2019 | 1368 | 0.030 |
Why?
|
Pakistan | 1 | 2016 | 296 | 0.030 |
Why?
|
DNA, Viral | 1 | 2022 | 2224 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2020 | 1093 | 0.030 |
Why?
|
Africa, Eastern | 1 | 2014 | 71 | 0.030 |
Why?
|
Apoptosis | 2 | 2020 | 9715 | 0.030 |
Why?
|
Actinomycosis | 1 | 2014 | 21 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2011 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8829 | 0.030 |
Why?
|
Relative Biological Effectiveness | 1 | 2016 | 323 | 0.030 |
Why?
|
Endocrinology | 1 | 2020 | 443 | 0.030 |
Why?
|
Aphasia | 1 | 2015 | 179 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21596 | 0.030 |
Why?
|
Pseudomonas Infections | 1 | 2018 | 608 | 0.030 |
Why?
|
Bangladesh | 1 | 2016 | 687 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6474 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 558 | 0.030 |
Why?
|
Clavicle | 1 | 2015 | 209 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2019 | 1284 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2002 | 2257 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3293 | 0.030 |
Why?
|
Up-Regulation | 1 | 2002 | 4211 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1606 | 0.030 |
Why?
|
Pharyngitis | 1 | 2014 | 215 | 0.030 |
Why?
|
Sulfonamides | 1 | 2002 | 1932 | 0.030 |
Why?
|
Protons | 2 | 2009 | 1126 | 0.030 |
Why?
|
Disease Progression | 1 | 2009 | 13256 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 19223 | 0.030 |
Why?
|
Device Removal | 1 | 2017 | 652 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2017 | 860 | 0.030 |
Why?
|
Cancer Vaccines | 1 | 2019 | 1021 | 0.030 |
Why?
|
Child | 6 | 2017 | 77478 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2638 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 729 | 0.020 |
Why?
|
Osteoradionecrosis | 1 | 2011 | 49 | 0.020 |
Why?
|
Brain Edema | 1 | 2015 | 617 | 0.020 |
Why?
|
Health Services | 1 | 2016 | 758 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3199 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2948 | 0.020 |
Why?
|
Bone Transplantation | 1 | 2015 | 907 | 0.020 |
Why?
|
Cranial Fossa, Anterior | 1 | 2009 | 13 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2017 | 2699 | 0.020 |
Why?
|
Texas | 1 | 2011 | 392 | 0.020 |
Why?
|
Osteotomy | 1 | 2015 | 823 | 0.020 |
Why?
|
Chronic Disease | 2 | 2015 | 9144 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2018 | 2128 | 0.020 |
Why?
|
India | 1 | 2016 | 2187 | 0.020 |
Why?
|
Biopsy | 2 | 2014 | 6756 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 839 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3618 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4187 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2016 | 2451 | 0.020 |
Why?
|
SEER Program | 1 | 2013 | 1507 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2016 | 1178 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3300 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9679 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5519 | 0.020 |
Why?
|
Cancer Care Facilities | 1 | 2011 | 401 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1411 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 1398 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1503 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2183 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2009 | 383 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3256 | 0.020 |
Why?
|
Paranasal Sinuses | 1 | 2009 | 249 | 0.020 |
Why?
|
Nose Diseases | 1 | 2007 | 79 | 0.020 |
Why?
|
Neutrons | 1 | 2006 | 76 | 0.020 |
Why?
|
Mandible | 1 | 2011 | 740 | 0.020 |
Why?
|
Cranial Fossa, Posterior | 1 | 2006 | 139 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3507 | 0.020 |
Why?
|
Fibroma | 1 | 2007 | 212 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 2006 | 125 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 1363 | 0.020 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2009 | 325 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2017 | 2522 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2017 | 3465 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3339 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 2011 | 763 | 0.020 |
Why?
|
Mass Screening | 1 | 2020 | 5238 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2015 | 2266 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2211 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4379 | 0.020 |
Why?
|
Mice | 2 | 2023 | 81045 | 0.010 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2006 | 285 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 24913 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2009 | 1203 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13403 | 0.010 |
Why?
|
Neurons | 1 | 2023 | 9325 | 0.010 |
Why?
|
Glycoproteins | 1 | 2011 | 2260 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8425 | 0.010 |
Why?
|
Carbon | 1 | 2006 | 686 | 0.010 |
Why?
|
Inflammation | 1 | 2002 | 10578 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2009 | 2110 | 0.010 |
Why?
|
Visual Fields | 1 | 2009 | 1049 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7770 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13655 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15056 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21821 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5062 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16331 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15194 | 0.010 |
Why?
|
Animals | 2 | 2023 | 168561 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 8969 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7153 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23387 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17400 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 4029 | 0.010 |
Why?
|
United States | 2 | 2013 | 69693 | 0.010 |
Why?
|
Infant | 1 | 2015 | 35070 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 40955 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8925 | 0.010 |
Why?
|